Literature DB >> 27896491

Clusters of cognitive impairment among different phenotypes of myotonic dystrophy type 1 and type 2.

Stojan Peric1, Vidosava Rakocevic Stojanovic2, Gorana Mandic Stojmenovic1, Vera Ilic1, Masa Kovacevic1, Aleksandra Parojcic1, Jovan Pesovic3, Milija Mijajlovic1, Dusanka Savic-Pavicevic3, Giovanni Meola4.   

Abstract

Neuropsychological examinations in myotonic dystrophy (DM) patients show a great variability of results from a condition of intellectual disability to the subtle cognitive impairments. It is unclear if different clusters of neuropsychological deficits appear in different phenotypes of DM, or if there are patients with no cognitive deficit at all. The aim of this study is to assess cognitive impairments among patients with different phenotypes of DM type 1 (DM1) and type 2 (DM2), and to potentially define cognitive clusters in these disorders. Study comprised 101 DM1 and 46 DM2 adult patients who were genetically confirmed. Patients underwent analysis of five cognitive domains (visuospatial, executive, attention, memory and language). Virtually all DM1 patients had cognitive defect with approximately 2-3 cognitive domains affected. On the other hand, one-third of DM2 patients had completely normal neuropsychological findings, and in other two-thirds approximately 1-2 domains were affected. Cluster analysis showed that in both diseases visuospatial and executive dysfunctions seemed to be the main cognitive defects, while memory and language impairments appeared in more severe phenotypes. Our results showed that a single form of DM1 or DM2 may consist of several cognitive clusters. Understanding of cognitive impairments in DM is very important to follow positive and side effects in ongoing and future clinical trials.

Entities:  

Keywords:  Cluster analysis; Cognitive impairment; Myotonic dystrophy; Neuropsychology

Mesh:

Year:  2016        PMID: 27896491     DOI: 10.1007/s10072-016-2778-4

Source DB:  PubMed          Journal:  Neurol Sci        ISSN: 1590-1874            Impact factor:   3.307


  31 in total

1.  Reduced cerebral blood flow and impaired visual-spatial function in proximal myotonic myopathy.

Authors:  G Meola; V Sansone; D Perani; A Colleluori; S Cappa; M Cotelli; F Fazio; C A Thornton; R T Moxley
Journal:  Neurology       Date:  1999-09-22       Impact factor: 9.910

2.  Transcranial sonography in patients with myotonic dystrophy type 1.

Authors:  Stojan Peric; Aleksandra Pavlovic; Vesna Ralic; Valerija Dobricic; Ivana Basta; Dragana Lavrnic; Vidosava Rakocevic Stojanovic
Journal:  Muscle Nerve       Date:  2014-05-15       Impact factor: 3.217

3.  Brain sonography insight into the midbrain in myotonic dystrophy type 2.

Authors:  Vidosava Rakocevic-Stojanovic; Stojan Peric; Dusanka Savic-Pavicevic; Jovan Pesovic; Sarlota Mesaros; Dragana Lavrnic; Zagorka Jovanovic; Aleksandra Pavlovic
Journal:  Muscle Nerve       Date:  2015-11-26       Impact factor: 3.217

4.  Assessment of a disease-specific muscular impairment rating scale in myotonic dystrophy.

Authors:  J Mathieu; H Boivin; D Meunier; M Gaudreault; P Bégin
Journal:  Neurology       Date:  2001-02-13       Impact factor: 9.910

5.  Subtle cognitive dysfunction in adult onset myotonic dystrophy type 1 (DM1) and type 2 (DM2).

Authors:  C Gaul; T Schmidt; G Windisch; T Wieser; T Müller; S Vielhaber; S Zierz; B Leplow
Journal:  Neurology       Date:  2006-07-25       Impact factor: 9.910

6.  Executive dysfunction and avoidant personality trait in myotonic dystrophy type 1 (DM-1) and in proximal myotonic myopathy (PROMM/DM-2).

Authors:  G Meola; V Sansone; D Perani; S Scarone; S Cappa; C Dragoni; E Cattaneo; M Cotelli; C Gobbo; F Fazio; G Siciliano; M Mancuso; E Vitelli; S Zhang; R Krahe; R T Moxley
Journal:  Neuromuscul Disord       Date:  2003-12       Impact factor: 4.296

7.  Abnormal functional brain connectivity and personality traits in myotonic dystrophy type 1.

Authors:  Laura Serra; Gabriella Silvestri; Antonio Petrucci; Barbara Basile; Marcella Masciullo; Elena Makovac; Mario Torso; Barbara Spanò; Chiara Mastropasqua; Neil A Harrison; Maria L E Bianchi; Manlio Giacanelli; Carlo Caltagirone; Mara Cercignani; Marco Bozzali
Journal:  JAMA Neurol       Date:  2014-05       Impact factor: 18.302

8.  The brain in myotonic dystrophy 1 and 2: evidence for a predominant white matter disease.

Authors:  Martina Minnerop; Bernd Weber; Jan-Christoph Schoene-Bake; Sandra Roeske; Sandra Mirbach; Christian Anspach; Christiane Schneider-Gold; Regina C Betz; Christoph Helmstaedter; Marc Tittgemeyer; Thomas Klockgether; Cornelia Kornblum
Journal:  Brain       Date:  2011-11-29       Impact factor: 13.501

9.  Cognitive deficits and CTG repeat expansion size in classical myotonic dystrophy type 1 (DM1).

Authors:  Stefan Winblad; Christopher Lindberg; Stefan Hansen
Journal:  Behav Brain Funct       Date:  2006-05-15       Impact factor: 3.759

10.  Cortical and Subcortical Grey and White Matter Atrophy in Myotonic Dystrophies Type 1 and 2 Is Associated with Cognitive Impairment, Depression and Daytime Sleepiness.

Authors:  Christiane Schneider-Gold; Barabara Bellenberg; Christian Prehn; Christos Krogias; Ruth Schneider; Jan Klein; Ralf Gold; Carsten Lukas
Journal:  PLoS One       Date:  2015-06-26       Impact factor: 3.240

View more
  11 in total

Review 1.  Repeat-associated RNA structure and aberrant splicing.

Authors:  Melissa A Hale; Nicholas E Johnson; J Andrew Berglund
Journal:  Biochim Biophys Acta Gene Regul Mech       Date:  2019-07-16       Impact factor: 4.490

2.  Brief assessment of cognitive function in myotonic dystrophy: Multicenter longitudinal study using computer-assisted evaluation.

Authors:  Gayle K Deutsch; Katharine A Hagerman; Jacinda Sampson; Gersham Dent; Jeanne Dekdebrun; Dana M Parker; Charles A Thornton; Chad R Heatwole; Sub H Subramony; Ami K Mankodi; Tetsuo Ashizawa; Jeffrey M Statland; W David Arnold; Richard T Moxley; John W Day
Journal:  Muscle Nerve       Date:  2022-02-28       Impact factor: 3.852

Review 3.  Myotonic Dystrophies: Targeting Therapies for Multisystem Disease.

Authors:  Samantha LoRusso; Benjamin Weiner; W David Arnold
Journal:  Neurotherapeutics       Date:  2018-10       Impact factor: 7.620

4.  Patient Input to Inform the Development of Central Nervous System Outcome Measures in Myotonic Dystrophy.

Authors:  Molly White
Journal:  Ther Innov Regul Sci       Date:  2020-01-22       Impact factor: 1.778

5.  Cognitive impairment in neuromuscular diseases: A systematic review.

Authors:  Marco Orsini; Ana Carolina; Andorinho de F Ferreira; Anna Carolina Damm de Assis; Thais Magalhães; Silmar Teixeira; Victor Hugo Bastos; Victor Marinho; Thomaz Oliveira; Rossano Fiorelli; Acary Bulle Oliveira; Marcos R G de Freitas
Journal:  Neurol Int       Date:  2018-07-04

Review 6.  Empathy In Neurodegenerative Diseases: A Systematic Review.

Authors:  Emanuele Pick; Johann R Kleinbub; Stefania Mannarini; Arianna Palmieri
Journal:  Neuropsychiatr Dis Treat       Date:  2019-11-22       Impact factor: 2.570

Review 7.  Molecular and Clinical Implications of Variant Repeats in Myotonic Dystrophy Type 1.

Authors:  Stojan Peric; Jovan Pesovic; Dusanka Savic-Pavicevic; Vidosava Rakocevic Stojanovic; Giovanni Meola
Journal:  Int J Mol Sci       Date:  2021-12-29       Impact factor: 5.923

8.  Cognitive function and its relationship with brain structure in myotonic dystrophy type 1.

Authors:  Kathleen E Langbehn; Ellen van der Plas; David J Moser; Jeffrey D Long; Laurie Gutmann; Peggy C Nopoulos
Journal:  J Neurosci Res       Date:  2020-02-13       Impact factor: 4.164

9.  Outcome Measures for Central Nervous System Evaluation in Myotonic Dystrophy Type 1 May Be Confounded by Deficits in Motor Function or Insight.

Authors:  Mark J Hamilton; John McLean; Sarah Cumming; Bob Ballantyne; Josephine McGhie; Ravi Jampana; Cheryl Longman; Jonathan J Evans; Darren G Monckton; Maria Elena Farrugia
Journal:  Front Neurol       Date:  2018-10-02       Impact factor: 4.003

10.  Regional brain atrophy in gray and white matter is associated with cognitive impairment in Myotonic Dystrophy type 1.

Authors:  Garazi Labayru; Ibai Diez; Jorge Sepulcre; Esther Fernández; Miren Zulaica; Jesús M Cortés; Adolfo López de Munain; Andone Sistiaga
Journal:  Neuroimage Clin       Date:  2019-11-06       Impact factor: 4.881

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.